Advertisement
Product › Details
StemSource™ cell bank
Next higher product group | cell bank_oo | |
Status | 2007-08-14 sales existent | |
Organisation | Cytori Therapeutics Inc. (Nasdaq: CYTX) | |
Group | Cytori (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for cell bank
- [1] Axol Bioscience Ltd.. (6/7/23). "Press Release: Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease". Cambridge, Edinburgh & Alderley Park....
- [2] Vita 34 AG. (2/8/19). "Press Release: Vita 34 Develops Cell Preparations as the Source Material for Immune Cell Therapies and Becomes Cell Bank". Leipzig....
- [3] TC BioPharm Ltd.. (8/2/17). "Press Release: TCB Selected for EU Horizon 2020 Funding to Progress Novel, Mass-market Cell Therapies to Clinical Trial". Scotland....
- [4] Merck KGaA. (6/15/17). "Press Release: Merck Expands Distribution Agreement with Public Health England". Darmstadt....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top